Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Coherus BioSciences Stock Price (Quote) NASDAQ:CHRS
$8.31 ( 5.06% ) Friday, 20th May 2022
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $7.24 | $10.56 | Friday, 20th May 2022 CHRS stock ended at $8.31. This is 5.06% more than the trading day before Thursday, 19th May 2022. During the day the stock fluctuated 7.87% from a day low at $7.75 to a day high of $8.36. |
| 90 days | $7.24 | $13.46 | |
| 52 weeks | $7.24 | $19.32 |
Historical Coherus BioSciences prices
| Date | Open | High | Low | Close | Volume |
| 2022-05-20 | $7.97 | $8.36 | $7.75 | $8.31 | 993 914 |
| 2022-05-19 | $7.47 | $7.94 | $7.34 | $7.91 | 1 533 044 |
| 2022-05-18 | $7.62 | $7.70 | $7.24 | $7.45 | 1 392 138 |
| 2022-05-17 | $7.70 | $7.95 | $7.61 | $7.91 | 1 037 288 |
| 2022-05-16 | $7.87 | $8.10 | $7.57 | $7.60 | 1 316 987 |
| 2022-05-13 | $7.93 | $8.02 | $7.54 | $7.95 | 1 498 405 |
| 2022-05-12 | $7.61 | $7.88 | $7.41 | $7.59 | 1 616 192 |
| 2022-05-11 | $8.41 | $8.58 | $7.73 | $7.75 | 1 387 882 |
| 2022-05-10 | $8.34 | $8.76 | $8.26 | $8.52 | 1 325 588 |
| 2022-05-09 | $8.10 | $8.60 | $7.98 | $8.03 | 1 522 784 |
| 2022-05-06 | $8.63 | $9.18 | $8.41 | $8.43 | 1 128 666 |
| 2022-05-05 | $9.68 | $9.90 | $8.73 | $8.82 | 1 221 872 |
| 2022-05-04 | $9.68 | $9.75 | $8.98 | $9.72 | 1 034 660 |
| 2022-05-03 | $9.66 | $9.87 | $9.35 | $9.71 | 962 827 |
| 2022-05-02 | $8.91 | $9.68 | $8.65 | $9.68 | 1 689 249 |
| 2022-04-29 | $9.30 | $9.56 | $9.01 | $9.04 | 582 671 |
| 2022-04-28 | $9.39 | $9.56 | $9.02 | $9.43 | 850 554 |
| 2022-04-27 | $9.35 | $9.60 | $9.22 | $9.28 | 575 719 |
| 2022-04-26 | $9.52 | $9.61 | $9.31 | $9.36 | 840 063 |
| 2022-04-25 | $9.49 | $9.76 | $9.34 | $9.62 | 855 111 |
| 2022-04-22 | $9.82 | $9.94 | $9.57 | $9.61 | 715 500 |
| 2022-04-21 | $10.16 | $10.39 | $9.81 | $9.86 | 1 025 500 |
| 2022-04-20 | $10.56 | $10.56 | $9.91 | $10.10 | 1 175 300 |
| 2022-04-19 | $10.47 | $10.75 | $10.26 | $10.38 | 752 300 |
| 2022-04-18 | $11.21 | $11.34 | $10.47 | $10.51 | 930 300 |
| 2022-04-14 | $11.60 | $11.65 | $11.20 | $11.25 | 603 490 |
| 2022-04-13 | $11.70 | $12.10 | $11.56 | $11.62 | 739 453 |
| 2022-04-12 | $12.24 | $12.56 | $11.52 | $11.81 | 936 425 |
| 2022-04-11 | $12.41 | $12.74 | $12.08 | $12.16 | 702 559 |
| 2022-04-08 | $12.51 | $12.93 | $12.46 | $12.50 | 472 100 |
| 2022-04-07 | $12.67 | $12.89 | $12.51 | $12.56 | 369 200 |
| 2022-04-06 | $12.48 | $12.96 | $12.48 | $12.75 | 514 400 |
| 2022-04-05 | $13.25 | $13.36 | $12.40 | $12.59 | 945 700 |
| 2022-04-04 | $12.90 | $13.39 | $12.85 | $13.23 | 511 400 |
| 2022-04-01 | $12.94 | $13.07 | $12.48 | $12.85 | 746 104 |
| 2022-03-31 | $12.84 | $13.29 | $12.84 | $12.91 | 330 566 |
| 2022-03-30 | $12.69 | $13.46 | $12.50 | $12.84 | 736 010 |
| 2022-03-29 | $12.35 | $12.99 | $12.05 | $12.76 | 1 193 800 |
| 2022-03-28 | $12.48 | $12.57 | $11.72 | $11.97 | 832 800 |
| 2022-03-25 | $12.82 | $12.82 | $12.38 | $12.43 | 453 100 |
| 2022-03-24 | $12.57 | $12.92 | $12.44 | $12.89 | 476 300 |
| 2022-03-23 | $12.48 | $12.94 | $12.45 | $12.51 | 816 100 |
| 2022-03-22 | $12.19 | $12.54 | $12.06 | $12.43 | 818 829 |
| 2022-03-21 | $13.22 | $13.31 | $12.11 | $12.16 | 817 470 |
| 2022-03-18 | $12.86 | $13.34 | $12.75 | $13.31 | 2 044 668 |
| 2022-03-17 | $12.82 | $13.02 | $12.57 | $12.84 | 667 800 |
| 2022-03-16 | $12.63 | $12.95 | $12.36 | $12.89 | 835 600 |
| 2022-03-15 | $12.23 | $12.94 | $11.98 | $12.54 | 876 200 |
| 2022-03-14 | $12.15 | $12.72 | $11.96 | $12.06 | 794 800 |
| 2022-03-11 | $12.58 | $12.82 | $12.27 | $12.33 | 584 000 |
Coherus Biosciences, Inc., a late-stage clinical biologics platform company, focuses on developing and commercializing biosimilar products worldwide. The companys product candidates include CHS-1701, a pegfilgrastim biosimilar candidate, which has completed a Phase I study for the prevention of chemotherapy-induced neutropenia; CHS-0214, an etanercept biosimilar candidate, which is in Phase III clinical trials for the treatment of rheumatoid ar... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
